002-Apr 15, 2025

Type 5 Diabetes: The Forgotten Illness Finds Its Name

Malnourishment, misdiagnosis, and medical awakening in the shadows of inequality.


🪔 Opening Whisper

“Sometimes, the most silent cries are heard not in clinics, but in the shadows of hunger.”


🧭 Compass: Where Are We Standing?

  • 📍 What? Type 5 Diabetes has been officially acknowledged by the International Diabetes Federation (IDF).
  • 🌐 Where? World Diabetes Congress, Bangkok, 2025.
  • 📌 Why? To identify, treat, and bring dignity to the millions living with a neglected disease.

🌿 The Core Highlights

🔹 What Is Type 5 Diabetes?

  • A malnutrition-related form of diabetes, previously undocumented in medical frameworks.
  • Affects lean and undernourished teenagers and young adults—mostly in low- and middle-income countries.
  • Estimated 20–25 million people worldwide suffer from this form.
  • Unlike Type 1 or Type 2, it stems from a severe insulin secretion defect.

🔹 Historical Journey

  • First observed in Jamaica (1955), later reported in India, Pakistan, and Sub-Saharan Africa.
  • Briefly recognised by the WHO in 1985, delisted in 1999 due to inadequate research follow-up.

🔹 Scientific and Clinical Recognition

  • New evidence proves that insulin treatment may harm Type 5 patients.
  • This has sparked a rethinking of diagnosis and treatment in malnourished populations.

🧠 Concept Explainer

⚖️ How It Differs from Other Types of Diabetes

CriteriaType 1Type 2Type 5 (Newly Recognised)
OnsetJuvenileAdultAdolescents, young adults
Body TypeLean or normalOverweightLean and malnourished
Primary CauseAutoimmuneInsulin resistanceInsulin secretion failure
TreatmentInsulinLifestyle + Oral medsUnder review – insulin may be harmful
PrevalenceGlobalGlobalAsia, Africa, under-resourced countries

🏥 What’s Being Done?

  • The International Diabetes Federation (IDF) has created a working group to:
    • Draft formal diagnostic and treatment guidelines (within 2 years).
    • Set up a global patient registry.
    • Launch training modules for healthcare providers.

🧩 Challenges in Diagnosis and Policy

  • Underdiagnosed due to lack of classification and awareness.
  • Often misclassified as Type 1, leading to ineffective or harmful treatment.
  • As common as HIV/AIDS, but without its global visibility or urgency.

📊 GS Paper Mapping

  • GS II: Health and Welfare Schemes | Vulnerable Sections
  • GS III: Science and Tech | Biotechnology | Medical Research
  • Essay Paper: Health as Human Dignity | Social Justice in Science

🔥 A Thought Spark — by IAS Monk

“For decades, millions lived with a nameless illness — invisible to systems, doctors, and data.
When we name the pain, we open a doorway to healing.”


🍃 Closing Whisper

Recognition is not merely academic—it is redemption, when science finally turns to face the forgotten.

Leave a Reply

Your email address will not be published. Required fields are marked *